Completed PHASE1 INTERVENTIONAL 3-arm NCT02867319

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Sponsor: Beijing Chaoyang District Centre for Disease Control and Prevention

Interventions A dose of ACYW135 meningococcal polysaccharide vaccine

Updated 6 times since 2017 Last updated: Aug 15, 2016 Started: Mar 31, 2016 Primary completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Meningococcal and is currently completed. Beijing Chaoyang District Centre for Disease Control and Prevention leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Feb 2017 — Jun 2018 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Chaoyang District Centre for Disease Control and Prevention

Data source: Beijing Chaoyang District Centre for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.